Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Using biomarkers to predict progression from clinically isolated syndrome to multiple sclerosis.
"Bright spotty lesions" on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis.
Shifting imaging targets in multiple sclerosis: From inflammation to neurodegeneration.
Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment.
Added benefit of fampridine is not proven
No quiet surrender: molecular guardians in multiple sclerosis brain.
UCSF Neuroimmunology Seminar
Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cells.
Exome sequencing in single cells from the cerebrospinal fluid in multiple sclerosis.
Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis.
T-cell response against varicella-zoster virus in fingolimod-treated MS patients.
Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.
Self-Reported Fatigue and Energy Cost During Walking Are Not Related in Patients With Multiple Sclerosis.
Medication withdrawal in relapsing-remitting multiple sclerosis: why not?
Social cognition in pediatric-onset multiple sclerosis (MS).
Role of the Programmed Death-1 (PD-1) pathway in regulation of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid β-induced memory impairment.
A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
MRI characteristics of familial and sporadic multiple sclerosis patients.
The genetics of multiple sclerosis: an up-to-date review.
SIGLEC1 and SIGLEC7 expression in circulating monocytes of patients with multiple sclerosis.
Granzyme B-Induced Neurotoxicity Is Mediated via Activation of PAR-1 Receptor and Kv1.3 Channel.
Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis (EAE) Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge.
Clinical Assessment of Orofacial Manifestations in 500 Patients With Multiple Sclerosis.
Substance Name: Phenytoin

Pages